How common are approved EB-2 NIW petitions?

EB-2 NIW petition outcomes vary based on the strength of evidence, the specific criteria addressed, and the adjudicating officer. Each case is evaluated individually based on its own merits and documentation.

How does the Bioengineering industry affect EB-2 NIW petition outcomes?

The Bioengineering sector has unique considerations for EB-2 NIW petitions. USCIS evaluates whether the petitioner's qualifications and contributions align with the specific requirements of the visa category. Industry context matters for demonstrating the significance and impact of the petitioner's work.

approved EB-2 (NIW)

Postdoctoral Researcher

Bioengineering · China · 2025-02-07

Processing Time

460 days

Decision Date

2025-02-07

Location

California

This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to continue her research in bioengineering, specifically focusing on engineering oncolytic viruses that selectively replicate in and kill cancer cells. Her work involves applying synthetic biology and protein-engineering tools to optimize viral delivery systems and developing novel assays for evaluating therapeutic efficacy and safety in preclinical models.

Framework Evaluation

3 of 3 criteria met

1 Substantial Merit and National Importance Met

The endeavor addresses urgent public-health needs and aligns with national priorities for innovative cancer treatments.

2 Well-positioned to Advance the Endeavor Met

The petitioner has a strong academic background, postdoctoral training, and a track record of securing grants and high-impact publications.

3 Waiver of Job Offer and Labor Certification Met

It is in the national interest of the United States to waive the requirements due to the petitioner's unique capacity to advance critical therapeutic technologies.

Why This Petition Was Approved

The petition was approved based on the petitioner's record of 5 peer-reviewed journal articles, 1 preprint, and 1 patent application, which garnered 375 citations. Evidence also included her service as a reviewer for 4 highly ranked journals and expert testimonials confirming the national importance of her cancer research. All three Dhanasar prongs were satisfied through her academic pedigree and technical contributions to molecular biology.

Evidence

Evidence Types

Peer Reviewed Publications

Citations

Patents

Reference Letters Independent

Grants

Judging Experience

Original Contributions

Government Alignment

Similar Cases

Research Fellow

Biotechnology · India

WeGreened EB-2 (NIW) approved

Maryland 289 days 2025-02-26

The petitioner proposes to continue her research in biotechnology, specifically developing novel combinatorial chemotherapies, immunotherapies, and plasma-based prognostic markers for cancer treatment. Her work focuses on investigating cancer signaling pathways and immune checkpoint regulation to enhance therapeutic efficacy and support personalized oncology care.

View Case

Scientist

Biotechnology · China

WeGreened EB-2 (NIW) approved

California 10 days 2023-08-24

The petitioner proposes to investigate novel strategies for diagnosis, drug delivery, and immunotherapy to develop new treatments for cancer. His work focuses on developing the AESOP platform, a microfluidic cell deformation system designed to improve the safety and efficiency of intracellular gene editing delivery.

View Case

Research Scientist

Biotechnology · Iran

WeGreened EB-2 (NIW) approved

Maryland 470 days 2025-02-28

The petitioner proposes to continue research in molecular biology focusing on the roles of specific proteins and signaling pathways in cancer development. The work involves studying compounds that disrupt survival signals in cancer cells to design highly effective, targeted therapies. The goal is to improve patient survival rates and enhance the precision of cancer treatments globally.

View Case

Scientist

Biotechnology · India

WeGreened EB-2 (NIW) rfe approved

Massachusetts 313 days 2025-02-03

The petitioner proposes to develop state-of-the-art cell and gene therapies to establish cures for debilitating diseases such as cancer and traumatic brain injury. The work focuses on enhancing therapeutic strategies through novel backpack technologies for cell engineering and advanced RNA-based therapeutic platforms.

View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Biotechnology cases More cases from China

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-02-07.

Browse all cases

View Original

At a Glance

Outcome approved

Processing 460 days

Criteria Met 3 / 3

Evidence Types 8

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813

Success Rate 53.7%

Sustained 2,046

Dismissed 1,671

EB-2 (NIW) Overview EB-2 (NIW) in China All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist

Postdoctoral Researcher

Proposed Endeavor

Framework Evaluation

Why This Petition Was Approved

Evidence

Similar Cases

Research Fellow

Scientist

Research Scientist

Scientist

Frequently Asked Questions

Browse More Cases

At a Glance

EB-2 (NIW) Case Data

Related Pages

Get Case Insights